Glims 4 mg (Tablet)

Unit Price: ৳ 8.88 (2 x 15: ৳ 266.40)
Strip Price: ৳ 133.20

Medicine Details

Category Details
Generic Glimepiride
Company Opsonin pharma ltd
Also available as
Glims 1 mg tablet Glims 2 mg tablet Glims 3 mg tablet

Title

  • Glims Tablet

Categories

  • Medicine
  • Diabetes Care

Description

  • Glims tablet is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with noninsulin dependent (Type II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone.
  • It may be used concomitantly with metformin when diet, exercise, and Glims or metformin alone does not result in adequate glycaemic control.
  • It is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycaemia cannot be controlled by diet and exercise in conjunction with an oral hypoglycaemic agent.

Dimensions

N/A

Color Options

N/A

Functions

  • Lowers blood glucose
  • Stimulates the release of insulin from functioning pancreatic beta cells
  • Improves sensitivity of beta cells to glucose stimulus
  • Reduces basal hepatic glucose production
  • Increases peripheral tissue sensitivity to insulin and glucose uptake

Materials

  • Sulfonylurea antidiabetic agent

Technical Specifications

  • Dosage: Initial dose is 1 mg once daily, with a maximum daily dose range of 1 to 4 mg for patients with well controlled diabetes.
  • Administration: Tablet must be swallowed with sufficient amount of liquid.
  • Interaction:
    • Potentiates Hypoglycaemic Action:
      • ACE inhibitors
      • Chloramphenicol
      • Fluconazole
      • Guanethidine
      • MAO-inhibitors
    • Attenuates Hypoglycaemic Action:
      • Calcium channel blockers
      • Corticosteroids
      • Diuretics
      • Nicotinic acid
  • Contraindications: Not suitable for the treatment of insulin dependent (type I) diabetes mellitus, diabetic ketoacidosis, diabetic coma, or in patients hypersensitive to Glimepiride, other sulfonylureas, other sulfonamides, severe hepatic dysfunction, severe impairment of renal function, and dialysis patients.
  • Pregnancy & Lactation: Not to be taken during pregnancy or breastfeeding.

Design Elements

Tablet form

Usability Features

  • Overdosage of sulfonylureas, including Glims, can produce hypoglycaemia. Mild hypoglycaemic symptoms without loss of consciousness or neurological findings should be treated aggressively with oral glucose and adjustments in drug dosage or meal patterns.

Precautions & Warnings

  • In the initial weeks of treatment, the risk of hypoglycaemia may be increased and necessitates careful monitoring.
  • Hypoglycaemia can almost be promptly controlled by immediate intake of carbohydrates (glucose or sugar).

Storage Conditions

Do not store above 30°C. Keep away from light and out of the reach of children.

Therapeutic Class

Sulfonylureas

Related Brands